Data from the Systolic Hypertension in the Elderly Program showed a 105-day improvement in the all-cause mortality of patients 60 years and older with systolic hypertension who were treated with chlorthalidone. In the Journal of the American Heart Association, researchers noted a 158-day gain in cardiovascular mortality in the diuretic group compared with a placebo group.

Related Summaries